Maintaining FDA 21 CFR Part 11 compliance across multiple manufacturing sites with thousands of monitoring points.

Global Pharma Company Streamlines FDA Compliance
Executive Summary
Challenge
Solution
Implemented validated monitoring solution with electronic signatures, audit trails, and automated compliance documentation.
Executive Summary
A global pharmaceutical manufacturer operating across 10 countries faced challenges maintaining consistent FDA compliance for temperature-sensitive products. By implementing a unified IoT-based environmental monitoring solution, the company achieved 100% audit readiness, improved process transparency, and significant operational efficiency gains within six months.
The Challenge
The company’s vast manufacturing and storage infrastructure included multiple facilities, each with varying monitoring systems.
This created key issues:
Fragmented data collection and manual temperature logging
Delayed response to temperature excursions
Difficulty meeting FDA 21 CFR Part 11 and WHO compliance requirements
Resource-heavy audits due to paper-based documentation
To ensure consistent product quality and compliance, the company needed a centralized, automated, and validated monitoring system.
Our Approach
Partnering with Ideabytes IoT, the pharma company adopted a comprehensive FDA-compliant environmental monitoring solution across all facilities.
Solution Highlights
IoT Data Loggers deployed across clean rooms, warehouses, and production zones
Cloud-based Dashboard with secure, role-based access
Automated Reports aligned with FDA 21 CFR Part 11 requirements
Real-time Alerts via email/SMS for temperature or humidity deviations
Digital Audit Trail ensuring traceability and accountability
Validation & Calibration Management integrated into the system
Conclusion
By integrating a validated, IoT-driven monitoring platform, the global pharma company transformed its FDA compliance management.
The solution provided end-to-end visibility, regulatory confidence, and operational excellence — setting a new benchmark for compliance in pharmaceutical manufacturing.